Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer

Molecular Carcinogenesis

Volumn 46, Issue 2, 2007, Pages 100-105

  Jun, Hee Jung ^a   Park, Sun Ha ^a   Lee, Won Kee ^b   Choi, Jin Eun ^b   Jang, Jin Sung ^b   Kim, Eun Jin ^a   Cha, Sung Ick ^a   Kim, Dong Sun ^b   Kam, Sin ^b   Kim, Chang Ho ^a   Kang, Young Mo ^a   Jung, Tae Hoon ^a   Park, Jae Yong ^a,b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Genetic susceptibility; Lung cancer; MDM2; p73; Polymorphism

Indexed keywords

PROTEIN MDM2; PROTEIN P73;

ADULT; APOPTOSIS; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE REGULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; KOREA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MDM2 GENE; P73 GENE; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

AGED; CASE-CONTROL STUDIES; CELL CYCLE; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS C-MDM2; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 33847048947     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20279     Document Type: Article

References (7)

1. Sellers TA, Bailey-Wilson JE, Potter JD, Rich SS, Rothschild H, Elston RC. Effect of cohort differences in smoking prevalence on models of lung cancer susceptibility. Genet Epidemiol 1992;9:261-271.
2. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000;18:2309-2315.
3. Hecht SS. Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol 2002;3:461-469.
4. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: The role of DNA damage and repair. Cancer Epidemiol Biomark Prev 2003;12:689-698.
5. Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 2004;96:1030-1036.
6. Kaelin WG. The emerging p53 gene family. J Natl Cancer Inst 1999;91:594-598.
7. Davis PK, Dowdy SF. p73. Int J Biochem Cell Biol 2001;33:935-939.